Samsung Bioepis First To File EU Lucentis Rival

Confirms SB11 Ranibizumab Biosimilar Candidate Accepted For Filing By EMA

 
• By David Wallace
  
Racers
Samsung Bioepis Is First Off The Marks With A Ranibizumab Filing • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products